West Virginia pharmaceutical plant closes, 1,500 jobs lost
CHARLESTON, West Virginia: A West Virginia pharmaceutical plant that employed some 1,500 people has closed, despite late efforts by unions and rights groups to keep the plant running.
Time was running out for workers at the former Mylan pharmaceutical plant in Morgantown, according to the Charleston Gazette Mail on Saturday.
Drugmaker Viatris Inc. announced in December that it would lay off workers at the end of July. The plant was previously operated by generic drug company Mylan, which merged with Upjohn in 2020 to form the new company.
Viatris, which has confirmed it will cut its global workforce by 20%, is now one of the world’s leading manufacturers of generic drugs.
The move left workers scrambling to find new jobs, with Viatris leaving the state of West Virginia, which sought to attract new businesses to boost its stagnant economy.
On July 21, labor and activist groups called on President Joe Biden to intervene. A new campaign, led by Our Revolution, a nonprofit political organization founded by Bernie Sanders, also urged Biden to use the Defense Production Act to stop the shutdown and create a task force to determine ways to enable the plant to continue to operate.
The White House has not responded to the shutdown or the group’s letter, the Charleston Gazette Mail reported.